UR-ENERGY INC. 14,722,200 Common Shares (no par value) and Warrants to Purchase 7,361,100 Common Shares Underwriting AgreementUnderwriting Agreement • February 4th, 2021 • Ur-Energy Inc • Gold and silver ores • New York
Contract Type FiledFebruary 4th, 2021 Company Industry JurisdictionUr-Energy Inc., a corporation continued under the Canada Business Corporations Act (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of 14,722,200 of its common shares (the “Firm Shares”), no par value per share (the “Common Shares”), and (ii) 14,722,200 warrants of the Company to purchase an aggregate of 7,361,100 Common Shares (the “Firm Warrants”). In addition, the Company has granted to the Underwriters an option to purchase (i) up to an additional 2,208,330 Common Shares pursuant to such option (the “Option Shares” and together with the Firm Shares, the “Shares”) and/or (ii) 2,208,330 additional warrants to purchase up to an additional 1,104,165 Common Shares (the “Option Warrants” and together with the Firm Warrants, the “Warrants”). Each Share is being sold together with one-half Warrant; and each full Warrant is exercisable for one Common Share at an exercise price of $1.35 per whole share. The Shar
Pre-Funded Warrants to Purchase 1,800,000 Shares Concert Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • January 28th, 2020 • Concert Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 28th, 2020 Company Industry JurisdictionIntroductory. Concert Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of 4,752,420 shares of its common stock, par value $0.001 per share of the Company (the “Shares”) and (ii) pre-funded warrants to purchase up to 1,800,000 Shares at an exercise price equal to $0.001 per share (the “Pre-Funded Warrants”). The Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 982,863 Shares as provided in Section 2. The additional Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” The Offered Shares and the Pre-Funded Warrants are herein referred to as the “Securities”. The Shares is